文献速递神经免疫

使用最小绝对收缩和选择算子(LASSO)识别多发性硬化临床与MRI结局的早期预测因素

Early Predictors of Clinical and MRI Outcomes Using Least Absolute Shrinkage and Selection Operator (LASSO) in Multiple Sclerosis.
PubMed 文献 · Ann Neurol · 2022-05-04

该研究分析704例多发性硬化患者,测量37个基线预测因素和10年结局,用LASSO筛选临床结局(侵袭性MS、良性MS、继发进展型MS)的共同预测因素,并比较MRI结局。LASSO选出的10个预测因素模型交叉验证AUC与全模型相当,MRI结局更受初始T2病灶体积和脑实质分数影响。

要点

  • LASSO筛选出10个临床结局共同预测因素,包括年龄、EDSS、锥体、小脑、感觉及肠道膀胱体征等。
  • 简化模型交叉验证AUC与全37因素模型相当:侵袭性MS 0.84 vs 0.81,良性MS 0.75 vs 0.73,SPMS 0.76 vs 0.75。
  • 10年MRI结局更受初始T2病灶体积和脑实质分数影响,而非临床因素。

核心结论

  • 使用LASSO建模可从有限的可获取临床特征中对多发性硬化进行早期预后判断。
  • 这些预测模型一旦整合到网络计算器中,或可用于临床治疗决策。

研究设计与样本

  • 研究分析了本中心704例多发性硬化发病时患者,测量37个基线人口学、临床、治疗和MRI预测因素及10年结局。
  • 主要目的是识别临床结局(侵袭性MS、良性MS、继发进展型MS)的共同预测因素,并研究MRI结局(T2病灶体积和脑实质分数)。
  • 比较全37预测因素模型与LASSO筛选的共同预测因素模型的性能,使用受试者工作特征曲线下面积(AUC)。

主要发现

  • 全37预测因素模型对临床结局预测性高:样本内AUC侵袭性MS为0.91,良性MS为0.81,SPMS为0.81。
  • LASSO选出10个临床结局共同预测因素:年龄、扩展残疾状态量表、锥体、小脑、感觉及肠道膀胱体征、定时25英尺步行≥6秒、发作恢复差、无感觉发作和至治疗时间。
  • 简化模型交叉验证AUC与全模型相当:侵袭性MS 0.84 vs 0.81,良性MS 0.75 vs 0.73,SPMS 0.76 vs 0.75。
  • 10年MRI结局更受初始T2病灶体积和脑实质分数影响,而非临床结局因素。

临床怎么用

  • 作者认为这些预测模型一旦整合到网络计算器中,或可用于临床治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to identify predictors in common between different clinical and magnetic resonance imaging (MRI) outcomes in multiple sclerosis (MS) by comparing predictive models. METHODS: We analyzed 704 patients from our center seen at MS onset, measuring 37 baseline demographic, clinical, treatment, and MRI predictors, and 10-year outcomes. Our primary aim was identifying predictors in common among clinical outcomes: aggressive MS, benign MS, and secondary-progressive (SP)MS. We also investigated MRI outcomes: T2 lesion volume (T2LV) and brain parenchymal fraction (BPF). The performance of the full 37-predictor model was compared with a least absolute shrinkage and selection operator (LASSO)-selected model of predictors in common between each outcome by the area under the receiver operating characteristic curves (AUCs). RESULTS: The full 37-predictor model was highly predictive of clinical outcomes: in-sample AUC was 0.91 for aggressive MS, 0.81 for benign MS, and 0.81 for SPMS. After variable selection, 10 LASSO-selected predictors were in common between each clinical outcome: age, Expanded Disability Status Scale, pyramidal, cerebellar, sensory and bowel/bladder signs, timed 25-foot walk ≥6 seconds, poor attack recovery, no sensory attacks, and time-to-treatment. This reduced model had comparable cross-validation AUC as the full 37-predictor model: 0.84 versus 0.81 for aggressive MS, 0.75 versus 0.73 for benign MS, and 0.76 versus 0.75 for SPMS, respectively. In contrast, 10-year MRI outcomes were more strongly influenced by initial T2LV and BPF than clinical outcomes. INTERPRETATION: Early prognostication of MS is possible using LASSO modeling to identify a limited set of accessible clinical features. These predictive models can be clinically usable in treatment decision making once implemented into web-based calculators. ANN NEUROL 2022;92:87-96.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Bose G, Healy BC, Lokhande HA, et al. Early Predictors of Clinical and MRI Outcomes Using Least Absolute Shrinkage and Selection Operator (LASSO) in Multiple Sclerosis. Ann Neurol. 2022. PMID: 35429009. doi:10.1002/ana.26370

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。